Skip to main content

PhD Program

The program provides funding to support PhD candidates to gain skills and undertake projects that will build capacity in the NSW Health system.

ProCan laboratory at Children's Medical Research Institute

Round three of NSW Health’s PhD Program is now open. This round will provide funding to support the recruitment of PhD candidates to undertake research projects in human bacteriophage therapy, including diagnostics, production and clinical translation.

The objectives of the Program are to:

  • attract high quality PhD students that strengthen successful phage therapy research programs
  • build workforce skills in the development and manufacture of phage therapy in NSW
  • create new opportunities for PhD students to study the development and manufacture of advanced therapeutics
  • improve graduate understanding of the diversity of employment opportunities in the NSW advanced therapeutics sector
  • improve graduate understanding of the commercialisation pathway for these therapies to support closer engagement with industry.

Applications for funding close on 26 March 2021. For more information please see the guidelines and application forms below.

Apply now

  • Phage Therapy PhD Program Application Form

    DOCX - 81 KB

Close

PhD recipients

Round one

  • Douglas Bellamy, University of New England and Hunter New England Local Health District
  • Ingrid Berling, University of Newcastle and Hunter Medical Research Institute
  • Melissa Ann Jackson, University of Newcastle and Hunter New England Local Health District
  • Rakshit Panwar, University of Newcastle and Hunter New England Local Health District
  • Emma Robson, University of Newcastle and Hunter New England Local Health District
  • Seth Tarrant University of Newcastle and Hunter New England Local Health District
  • Taylor Braund, University of Sydney and The Westmead Institute for Medical Research
  • Samantha Carlson, University of Sydney and The Sydney Children’s Hospital Network
  • Cristyn Davies, University of Sydney and The Sydney Children’s Hospital Network
  • Elizabeth Highton-Williamson, University of Sydney
  • Malinda Itchins, University of Sydney and Kolling Institute of Medical Research
  • Jessica Lee, University of Technology Sydney and Sydney Local Health District
  • Julee McDonagh, University of Technology Sydney and St Vincent’s Health Network
  • Aedan Roberts, University of Technology Sydney and The Sydney Children’s Hospital Network
  • Amanda Rush, University of Sydney and The Sydney Children’s Hospital Network Health
  • Christine Sanderson, University of Technology Sydney and South Eastern Sydney Local Health District
  • Jackie Yim, University of Technology Sydney and University of Sydney
  • Patricia Zajaczkowski, University of Technology Sydney and South Western Sydney Local Health District
  • Carlos El Haddad, Western Sydney University and South Western Sydney Local Health District
  • Saina Paul, Charles Sturt University and NSW Health Pathology
  • Lili Yuen, Western Sydney University and South Eastern Sydney Local Health District
  • Nicola Meagher, University of New South Wales and South Eastern Sydney Local Health District
  • Kelly Thompson, University of New South Wales and The George Institute for Global Health
  • Jeannette Walsh, University of New South Wales and NSW Ministry of Health
  • Shiying Zheng, University of New South Wales and South Eastern Sydney Local Health District
  • Kara Cappetta, University of Wollongong and Australian Health Services Research Institute
Close

Updated 10 months ago